Events
MC Services AG, a leading international public relations and investor relations firm, announced that it will support the 25th annual BIO-Europe® 2019, Europe’s largest partnering conference for the global life sciences industry, as a media partner.
PharmaMar has presented data from the Phase IV NIMES-ROC clinical trial with its marine-derived anti-tumor compound, Yondelis®, at the European Congress of Oncological Gynecology, being held from 2-5 November in Athens, Greece..
Preclinical results support the therapeutic potential of KB-1801 for the prevention of Cardiac Surgery-Associated Acute Kidney Injury and advancement into clinical development
Certara will host two Phoenix WinNonlin™ Lunch and Learns and also lead 18 workshop, presentation and poster sessions on model-informed drug development
Esperion announced that pooled analyses from four Phase 3 clinical trials of bempedoic acid will be presented at the American Heart Association Scientific Sessions in Philadelphia on Sunday, November 17, 2019.
Company to Highlight Potential of Phase 3 Precision Antibiotic Ridinilazole at the 7th Annual C. diff. Conference and Health EXPO
Presentations demonstrate how to employ real-world evidence to compare the cost-effectiveness and therapeutic benefit of different medical interventions
A key focus of the Sensors USA part of the IDTechEx Show! will be Point-of-Care Biosensors.
A shortage of qualified personnel may be a drag factor in cell and gene therapies; in China 100,00L of capacity will need to be added every year to meet bio demand
Keynote addresses industry shifts based on recent advancements in monoclonal antibody drug manufacturing
PRESS RELEASES